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Specificity of dermal mucin in the
diagnosis of lupus erythematosus:
comparison with other dermatitides
and normal skin†
Increased dermal mucin is a feature of lupus erythematosus (LE);
however, its amount and distribution have not been well
characterized. The differentiation of LE from other forms of
dermatitis can be challenging when other features of LE are
subtle or equivocal. One hundred and thirty-five skin specimens
showing LE, graft vs. host disease, erythema multiforme/fixed
drug eruption, lichen planus, polymorphous light eruption
(PMLE), urticaria, eczematous dermatitis and psoriasis and
normal skin with and without photodamage were collected. The
amounts of mucin in the papillary, superficial reticular and deep
reticular dermis were scored from 0 to 3 on hematoxylin–eosin
(H&E) and alcian blue (AB) stains, and compared between
groups. The mean scores in the reticular dermis were significantly
higher in LE than in other categories except PMLE and
eczematous dermatitis. A combined H&E+AB score of ≥5 in the
superficial reticular dermis gave an overall specificity of 85.7% for
LE. Mucin in the papillary dermis failed to distinguish among
entities. Normal photodamaged skin showed significantly more
mucin in the superficial reticular dermis compared to
non-photodamaged skin. While LE is associated with increased
mucin deposition, scant to moderate amount of mucin alone has
limited specificity and is common in other dermatitides or
photodamaged skin.
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Increased dermal mucin is one of the clas-
sic features of cutaneous lupus erythematosus
(LE); however, the amount and the distribu-
tion of mucin have not been well characterized.
Differentiation of LE from other inflammatory
dermatitides can be challenging when scant to
moderate amount of dermal mucin is present,
but other classic features of LE are subtle or
equivocal.
Increased dermal mucin and superficial to
deep perivascular and periadnexal lymphocytic
infiltrate are fairly constant histopathologic
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features of cutaneous LE.1,2 Additional findings
such as interface dermatitis, basement mem-
brane thickening and follicular plugging are
seen at varying frequencies depending on the
specific variant and chronicity of cutaneous
LE.3–6 While the diagnosis of LE is straight-
forward when all of the above histopathologic
features are present in conjunction with clas-
sic clinical presentation, diagnostic difficulty
arises when clinical information is limited and
when only few classic features are observed
histopathologically. For example, other inter-
face or perivascular dermatitides may present
with variable amount of dermal mucin and thus
closely mimic cutaneous LE. It also remains
unclear whether chronic sun exposure may
contribute to mucin deposition to a certain
degree. To our knowledge, study on the amount
of dermal mucin in these non-LE conditions is
lacking in the current literature.
Our objective was to address the above diagnos-
tic challenge by comparing the quantity and the
distribution of dermal mucin in cutaneous LE
to a variety of interface, perivascular, spongiotic
and psoriasiform dermatitides as well as normal
skin without dermatitis. We also aimed to study
the effect of chronic sun exposure on mucin
deposition by comparing normal skin with and
without solar elastosis.
Materials and methods
After approval by the Institutional Review Board,
the surgical pathology database at University of
Michigan was searched for ‘lupus erythemato-
sus’, ‘tumid lupus’, ‘discoid lupus’, ‘subacute
cutaneous lupus’, ‘systemic lupus’, ‘eczema’,
‘psoriasis’, ‘lichen planus’ (LP), ‘graft vs. host
disease’ (GVHD), ‘erythema multiforme’ (EM),
‘fixed drug eruption’ (FDE), ‘urticaria’ and
‘polymorphous light eruption’ (PMLE) between
years 2010 and 2014. All pathologic slides were
retrospectively reviewed and correlated with
clinical data (obtained from requisition form
and/or electronic medical record) to confirm
the original diagnoses. Cases with diagnos-
tic uncertainty were eliminated. ‘Eczematous
dermatitis’ refers to cases showing a primarily
spongiotic pattern, including atopic dermatitis,
contact dermatitis, nummular dermatitis and
eczematous drug reaction. Normal skin samples
with and without evidence of photodamage
(solar elastosis) were obtained from the tip
margins of wide local excisions performed for
melanoma and Merkel cell carcinoma.
Both hematoxylin–eosin (H&E)- and alcian
blue (AB)-stained sections were evaluated for
dermal mucin in three different compartments:
papillary dermis, superficial reticular dermis and
deep reticular dermis. The amount of mucin
in each compartment was scored separately on
H&E and AB as follows: 0, absent; 1 , scant wisps
of mucin that are barely noticeable; 2, moder-
ate amount of mucin almost filling the spaces
between collagen fibers; or 3, abundant mucin
pools filling and expanding the spaces between
collagen fibers. The H&E and AB scores in
each compartment were then combined to give
a total score of 0–6. Four selected cases were
also stained with colloidal iron for comparison.
Chi-square and two-tailed t-tests were performed
between groups. A p-value of <0.05 was consid-
ered statistically significant. The specificities and
sensitivities of dermal mucin for the diagnosis of
LE were calculated using different cut-off com-
bined scores.
Results
A total of 135 skin samples, including cutaneous
LE (n= 35), GVHD (n= 8), EM/FDE (n= 9),
LP (n= 15), PMLE (n= 11), urticaria (n= 8),
eczematous dermatitis (n= 8), psoriasis (n= 11),
normal skin with solar elastosis (n= 16) and nor-
mal skin without solar elastosis (n= 14) were
selected. The LE cases included discoid (n= 8),
subacute cutaneous (n= 7), systemic (n= 4),
tumid (n= 13) and not-otherwise-specified
(n= 3) subtypes. None of the patients in the
non-LE groups had known history of LE.
The mean combined (H&E+AB) mucin
scores for all entities are summarized in Table 1.
Four specimens were superficial and were
excluded from the calculations for the deep
reticular dermal compartment. Sixteen cases
(11.9%) had a discrepancy of at least two score
points between H&E and AB in at least one com-
partment. The p-values obtained from two-tailed
t-tests between groups are shown in Table 2.
Significantly more mucin was present in both
superficial and deep reticular dermis in LE when
compared to GVHD, EM/FDE, LP, urticaria,
psoriasis and normal skin (Fig. 1). However, no
significant difference was found when compar-
ing LE with PMLE and eczematous dermatitis
in all three compartments (Figs 2 and 3). Mucin
in the papillary dermis failed to distinguish LE
from other entities. Normal photodamaged
skin (with solar elastosis) showed significantly
more mucin in the superficial reticular dermis
compared to normal non-photodamaged skin
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Table 1. Mean combined (H&E+AB) mucin scores
Condition n
Papillary
dermis
Superficial
reticular
dermis
Deep
reticular
dermis
LE (all subtypes) 35 3.17 4.57 2.83
DLE 8 2.88 4.25 2.38
SCLE 7 3.71 4.71 2.57
SLE 4 3.00 3.75 2.25
TLE 13 3.15 4.92 3.38
NOS 3 3.00 4.67 3.00
GVHD 8 4.00 2.50 1.13
EM/FDE 9 2.89 2.67 1.22
LP 15 3.13 2.27 0.75
PMLE 11 3.55 4.09 2.64
Urticaria 8 3.13 3.38 1.75
Eczematous 8 2.88 3.50 2.00
Psoriasis 11 3.18 3.18 1.20
Normal,
photodamaged
16 3.13 3.06 1.44
Normal,
non-photodamaged
14 2.71 2.07 0.86
AB, Alcian blue; DLE, discoid lupus erythematosus; EM, erythema
multiforme; FDE, fixed drug eruption; GVHD, graft vs. host dis-
ease; H&E, hematoxylin–eosin; LE, lupus erythematosus; LP, lichen
planus; n, number of cases; NOS, not-otherwise-specified; PMLE,
polymorphous light eruption; SCLE, subacute cutaneous lupus ery-
thematosus; SLE, systemic lupus erythematosus; TLE, tumid lupus
erythematosus.
(without solar elastosis) (p = 0.0140); a similar
difference was also observed with AB scores
alone (p = 0.0007) (Fig. 4). Other than LE and
PMLE, none of the entities showed significant
differences in the amount of superficial reticular
dermal mucin compared to normal skin.
The sensitivities and the specificities of reticu-
lar dermal mucin for LE against other dermati-
tides are listed in Table 3. Compared to the
superficial reticular dermis, mucin in the deep
reticular dermis yielded the highest specificities
and the lowest sensitivities. Similarly, using a
higher combined score (5 and above) resulted
in higher specificities and lower sensitivities com-
pared to a lower cut-off (4 and above).
Discussion
Although the distinction between LE and other
inflammatory dermatitides in the setting of scant
to moderate amount of dermal mucin presents a
diagnostic dilemma that is not uncommon, it has
drawn little attention in the literature. To address
this issue, we performed a retrospective analy-
sis on confirmed cases of LE, GVHD, EM/FDE,
LP, PMLE, urticaria, eczematous dermatitis and
psoriasis to characterize the amount and the
Table 2. Comparison of combined (H&E+AB) mucin scores
(p-values from two-tailed t-tests)
Papillary
dermis
Superficial
reticular
dermis
Deep reticular
dermis
LE vs. GVHD 0.1353 0.0015 0.0027
LE vs. EM/FDE 0.5910 0.0009 0.0019
LE vs. LP 0.9324 <0.0001 <0.0001
LE vs. PMLE 0.4670 0.3240 0.6733
LE vs. urticaria 0.9359 0.0417 0.0476
LE vs. eczematous 0.5997 0.0580 0.1256
LE vs. psoriasis 0.9824 0.0074 0.0019
Photodamaged normal vs.
non-photodamaged
normal
0.2413 0.0140 0.0821
LE vs. normal* 0.4383 <0.0001 <0.0001
GVHD vs. normal* 0.0109 0.8506 0.9136
EM/FDE vs. normal* 0.9096 0.8799 0.8668
LP vs. normal* 0.5876 0.3438 0.1960
PMLE vs. normal* 0.1429 0.0006 <0.0001
Urticaria vs. normal* 0.6683 0.1107 0.1268
Eczematous vs. normal* 0.8912 0.0510 0.0331
Psoriasis vs. normal* 0.4765 0.1718 0.9275
AB, Alcian blue, EM, erythema multiforme; FDE, fixed drug eruption;
GVHD, graft vs. host disease; H&E, hematoxylin–eosin; LE, lupus
erythematosus (all subtypes); LP, lichen planus; PMLE, polymorphous
light eruption.
Boldface indicates statistical significance (p< 0.05).
*All normal cases with and without photodamage.
location of dermal mucin in these entities. We
hypothesized that increased dermal mucin may
be seen in a variety of dermatitides, and there-
fore has limited specificity for LE in the absence
of other classic features.
Dermal mucin is composed of various gly-
cosaminoglycans, which are long polymers that
are polyanionic and contain repeating disaccha-
ride units. Glycosaminoglycans can be divided
into six major groups, including chondroitin
sulfate, dermatan sulfate, heparin, heparin
sulfate, hyaluronan and keratan sulfate.7,8
Depending on the specific type, glycosaminogly-
cans play a variety of roles including cell–cell
interactions, absorbing water and binding to
extracellular protein.9–13 Additionally, there
is some evidence to suggest that glycosamino-
glycans function immunologically by activating
macrophages, dendritic cells and neutrophils,
and may inhibit the effects of tumor necrosis
factor-alpha and interleukin-6.14–16 It has been
shown that incubation of normal fibroblasts
with serum from a patient with LE induced
production of glycosaminoglycans.17 While the
exact mechanism is poorly understood, it is
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Fig. 1. Scoring of dermal mucin on hematoxylin–eosin (H&E) and alcian blue (AB) stains. Colloidal iron stain was also performed
on these selected cases for comparison. Mucin is appreciated as a blue-gray, beaded, stringy material in between and attached to
collagen fibers on H&E, which gives a blue color on AB and colloidal iron stains. A, B and C) An example of graft vs. host disease
without mucin (combined score= 0). D, E and F) An example of lichen planus with scant wisps of mucin barely noticeable on
H&E and AB stains (combined score= 1+ 1= 2). Note an apparently greater amount of mucin is appreciable in a patchy fashion
on colloidal iron stain. G, H and I) An example of erythema multiforme with moderate amount of mucin almost filling the spaces
between collagen fibers (combined score= 2+ 2= 4). Again, more intense staining is noted on colloidal iron compared to AB,
with the former showing diffuse mucin deposition between collagen fibers. J, K and L) An example of tumid lupus erythematosus
with abundant mucin filling and expanding the spaces between collagen fibers (combined score= 3+ 3= 6). Similar findings are
observed on colloid iron stain. [H&E (A, D, G and J), AB (B, E, H and K) and colloidal iron (C, F, I and L), original magnifications
×400]
thought that mucin accumulation is predomi-
nantly driven by fibroblast and endothelial cell
production or decreased degradation.18,19 It is
therefore not surprising that a variety of inflam-
matory skin diseases may also display increased
dermal mucin.
We evaluated both conventional and AB stains
in order to attempt to provide more specific
and objective scores on the quantification of
mucin, although similar trends were observed
on either H&E or AB alone. Discrepancies of
at least two score points between H&E and AB
were observed in only a small subset (11.9%) of
cases, which may be attributable to slight differ-
ences in tissue processing and staining. It is also
noteworthy that colloidal iron stain, another
special stain commonly used to highlight dermal
mucin, tends to show more robust staining. As
illustrated in Fig. 1, assessment of scores should
be adjusted accordingly when colloidal stain is
used instead of AB. By dividing the dermis into
three compartments, we found that papillary
dermal mucin was a frequent finding across
different entities including normal skin, and
provided no diagnostic value in distinguishing
LE from other conditions examined in this
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Fig. 2. An example case of polymorphous light eruption. A) Low magnification shows a superficial to mid dermal perivascular
lymphocytic infiltrate with mild papillary dermal edema, closely mimicking tumid lupus erythematosus. Moderate amount of mucin
is present in both (B) superficial reticular dermis and (C) deep reticular dermis. [hematoxylin–eosin, original magnification ×40
(A); alcian blue, original magnifications ×400 (B and C)]
Fig. 3. An example case of eczematous dermatitis. A) Low magnification shows epidermal spongiosis and a mild superficial
perivascular lymphocytic infiltrate. B) Abundant mucin is present in the superficial reticular dermis of this example. C) Only
scant mucin is present in the deep reticular dermis. [hematoxylin–eosin, original magnification ×40 (A); alcian blue, original
magnifications ×400 (B and C)]
study. As both superficial and deep reticular
dermis yielded similar results, and four biopsy
specimens were devoid of deep reticular dermis,
the superficial reticular dermis is considered
sufficient for the evaluation of mucin deposi-
tion. While the mean combined scores obtained
from both the superficial and the deep reticular
dermis are highly comparable, it is clear that
the presence of moderate or abundant amount
of mucin in the deep reticular dermis gives the
highest specificity for LE. This is in agreement
with common belief that deep dermal mucin is
more specific than superficial dermal mucin.
Tumid LE is characterized by abundant der-
mal mucin deposition typically exceeding the
amount seen in other LE subtypes, although
no objective quantification has been reported
to our knowledge. Our study included 22 cases
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Fig. 4. Dermal mucin in non-photodamaged skin versus photodamaged skin. A and B) An example of non-photodamaged skin on
the calf taken from the tip of a melanoma excision shows no mucin. C and D) Photodamaged skin on the scalp taken from the
tip of a melanoma excision shows moderate amount of mucin. [hematoxylin–eosin (A and C) and alcian blue (B and D), original
magnifications ×400]
Table 3. Sensitivities and specificities of dermal mucin for lupus erythematosus against other dermatitides
Superficial reticular dermis Deep reticular dermis
Combined score≥ 4 Combined score≥ 5 Combined score≥ 4
Sensitivity (%) Specificity (%) Sensitivity (%) Specificity (%) Sensitivity (%) Specificity (%)
LE 74.3 – 60.0 – 34.3 –
LE vs. all other dermatitides – 64.3 – 85.7 – 93.9
LE vs. GVHD – 87.5 – 87.5 – 100
LE vs. EM/FDE – 77.8 – 88.9 – 100
LE vs. LP – 93.3 – 100.0 – 100
LE vs. PMLE – 27.3 – 63.6 – 81.8
LE vs. urticaria – 50.0 – 75.0 – 100
LE vs. eczematous – 37.5 – 87.5 – 100
LE vs. psoriasis – 63.6 – 90.9 – 90.0
EM, erythema multiforme; FDE, fixed drug eruption; GVHD, graft vs. host disease; LE, lupus erythematosus; LP, lichen planus; PMLE,
polymorphous light eruption.
of non-tumid LE and 13 cases of tumid LE in
order to avoid over-representation of the latter.
As expected, tumid LE showed the highest mean
scores in the reticular dermis in this study. Of
the non-tumid subtypes, subacute cutaneous LE
and discoid LE tend to exhibit greater amounts
of mucin than systemic LE, although the small
sample sizes preclude conclusive comparison.
Our data show that scant to moderate amount
of dermal mucin can be seen in a variety of
dermatitides besides LE, including those with
spongiotic, psoriasiform, interface and/or
perivascular tissue reaction patterns. While
this creates little confusion in spongiotic and
psoriasiform dermatitides, dermal mucin may
present a diagnostic challenge when an interface
process or a perivascular lymphocytic infiltrate
is observed in conjunction with any clinical sus-
picion for LE. In this study, LE shows statistically
highermean combinedmucin scores in the retic-
ular dermis compared to all other dermatitides
except PMLE and eczematous dermatitis. Of
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all the non-LE dermatitides examined, PMLE,
eczematous dermatitis and urticaria exhibit
the greatest amounts of dermal mucin. Using
dermal mucin as an independent factor, a com-
bined score of 5 and above – corresponding to
abundant mucin on H&E and/or AB stains – is
required to distinguish these three entities
from LE.
Based on our results, distinction between
PMLE and tumid LE proves to be most
problematic. Both entities present clinically
as erythematous papules and plaques on
sun-exposed skin.20,21 Histopathologically, both
are characterized by a superficial to deep perivas-
cular lymphocytic infiltrate. While dermal mucin
is another key feature of tumid LE,22 our data
show for the first time that it is also a common
finding in PMLE. This holds true for all three
dermal compartments examined. To add to this
diagnostic pitfall, a previous study has shown
that marked papillary dermal edema (another
characteristic feature of PMLE) may also be
observed in acute cutaneous LE and discoid
LE.23 In challenging cases, CD123 immunohis-
tochemistry may serve as a useful discriminator,
as it highlights plasmacytoid dendritic cells
which are present in greater numbers and often
in clusters in LE but not in PMLE.24,25
Interestingly, we also observed considerable
amount of dermal mucin in eczematous dermati-
tis. Although the mean scores of eczematous
dermatitis were lower than those of LE, the
differences did not reach statistical significance.
Morphologic distinction between eczematous
dermatitis and LE usually poses little diagnostic
challenge, as spongiosis is not typically seen
in LE, and interface change is not a feature
of eczematous dermatitis. A potentially prob-
lematic scenario would be an eczematous drug
reaction, in which other minor reaction patterns
including interface change may be observed.
Recognition of mucin deposition as a common
finding in eczematous dermatitis is therefore
important in avoiding overdiagnosis of LE in
this setting.
Mucin deposition in urticaria presents
another potential diagnostic dilemma. Clas-
sic urticaria is characterized by a scant
perivascular and interstitial neutrophilic infil-
trate. Such reaction pattern has also been
described in association with systemic LE
as well as with other autoimmune diseases
under different terminologies, including ‘neu-
trophilic urticarial dermatosis’,26 ‘non-bullous
neutrophilic LE’,27 ‘systemic LE-associated neu-
trophilic dermatosis’,28 ‘autoimmunity-related
neutrophilic dermatosis’,29 among others. Der-
mal mucin was observed in a subset of cases in
various series, although the amount of mucin
was not specified.27–29 None of our patients
with urticaria had any known history or clinical
suspicion for LE. Our urticaria cases also lacked
other typical features of systemic LE-associated
neutrophilic dermatosis, such as basal vacuolar
change along the dermoepidermal junction and
prominent leukocytoclasis.26–29 Nevertheless,
careful clinicopathologic correlation is required
in the evaluation of urticarial dermatosis espe-
cially in the presence of dermal mucin, in
order to exclude a paucicellular neutrophilic
dermatosis associated with systemic LE.
Other interface dermatitides examined in
this study (GVHD, EM/FDE and LP) displayed
significantly less dermal mucin compared to LE.
A combined score of 4 and above (at least mod-
erate amount on both H&E and AB stains) in the
superficial reticular dermis provides reasonable
specificities in distinguishing these conditions
from LE. On the other hand, the difference
between LE and psoriasiform dermatitis showed
narrower margin. Unlike interface dermatitides,
however, psoriasis can be easily distinguished
from LE based on its other features such as
psoriasiform hyperplasia, hypogranulosis and
confluent neutrophilic parakeratosis.
Using solar elastosis as an indicator of pho-
todamage, we found increased deposition of
dermal mucin in photodamaged normal skin
compared to non-photodamaged normal skin.
The difference is statistically significant using
both combined H&E+AB scores as well as AB
scores alone; the latter argues against over-
interpretation of solar elastosis on H&E as
mucin deposition. While this may be common
knowledge, our study provides the first objective
proof of this phenomenon to our knowledge.
We hypothesize that increased mucin in this
setting is a result of degenerative change asso-
ciated with photodamage, and possibly a failed
reparative attempt. We also suggest that in
photodamaged skin, the presence of increased
dermal mucin is less reliable in distinguish-
ing LE from other dermatitides than in non-
photodamaged skin.
In conclusion, this study confirms increased
deposition of dermal mucin in cutaneous LE
compared to other common dermatitides,
although many non-LE conditions may also dis-
play scant to moderate amount of mucin. While
histopathologic evaluation for dermal mucin
remains key to the diagnosis of LE, its speci-
ficity as an independent factor is limited when
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present in low quantity or in a background of
significant photodamage. Recognition of these
findings will potentially avoid overdiagnosis of
LE and inappropriate treatment. It should be
emphasized that accurate diagnosis of cutaneous
LE entails careful evaluation for all histopatho-
logic features and adequate clinicopathologic
correlation.
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